What it's for (Indications)
- Hydrocortisone, a corticosteroid, is broadly indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
- When administered topically or rectally, such as in formulations exemplified by Posterisan Forte (which typically combines hydrocortisone with a local anesthetic for anorectal conditions), its primary indications include the management of conditions affecting the skin and mucous membranes.
- This encompasses inflammatory and pruritic anal conditions such as hemorrhoids, proctitis, anal fissures, and pruritus ani, where reduction of inflammation, swelling, and itching is desired.
- It is also used for various forms of eczema, dermatitis, and psoriasis where inflammation and itching are prominent symptoms requiring local corticosteroid therapy.
- The specific strength and formulation dictate its precise applications and suitability for different anatomical sites or conditions, always requiring a thorough medical evaluation for appropriate prescription.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | Dosage of hydrocortisone varies significantly based on the formulation (cream, ointment, lotion, foam, suppositories), strength, site of application, and the severity and extent of the condition being treated. For topical preparations, a thin film is typically applied to the affected skin area one to four times daily, as directed by a healthcare professional. For rectal applications, such as with suppositories or anorectal creams (e.g., Posterisan Forte, which contains hydrocortisone), the usual regimen involves application one to two times daily, often after bowel movements. The duration of therapy should be kept as short as possible to achieve the desired therapeutic effect, generally not exceeding two weeks for topical use without reassessment, especially on sensitive areas or in pediatric patients. Prolonged use, application to large surface areas, or use under occlusive dressings should be strictly avoided due to increased risk of systemic absorption and adverse effects. |
Safety & Warnings
Common Side Effects
- As with all medications, hydrocortisone can cause side effects, particularly with prolonged use or improper application.
- Local adverse reactions commonly reported include burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, and miliaria.
- When applied topically, especially over large areas, for prolonged periods, or under occlusive dressings, sufficient systemic absorption may occur to produce reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing's syndrome, hyperglycemia, and glucosuria.
- Pediatric patients may be more susceptible to systemic toxicity.
- Other systemic effects can include increased intraocular pressure, glaucoma, cataracts, and growth retardation in children.
Serious Warnings
- Black Box Warning: While hydrocortisone, particularly in its topical or rectal forms (such as exemplified by Posterisan Forte), does not typically carry an FDA-mandated Black Box Warning, it is imperative to include a 'Serious Warnings' section due to significant potential risks associated with its use. Prolonged use, application to large surface areas, use under occlusive dressings, or use in individuals with compromised skin barrier function, particularly in pediatric patients, can lead to significant systemic absorption. This systemic absorption can result in hypothalamic-pituitary-adrenal (HPA) axis suppression, potentially leading to adrenal insufficiency upon abrupt discontinuation. Manifestations of Cushing's syndrome, hyperglycemia, and glucosuria have also been reported. These serious systemic effects underscore the necessity of using the lowest effective dose for the shortest possible duration. Patients should be closely monitored for signs of systemic toxicity, and therapy should be tapered gradually if HPA axis suppression is suspected or confirmed to avoid acute adrenal crisis. Avoid use on open wounds, damaged skin, or mucous membranes where absorption is significantly increased.
- Hydrocortisone therapy requires careful consideration due to potential for local and systemic adverse effects.
- Systemic absorption of topical or rectal corticosteroids can lead to reversible HPA axis suppression, Cushing's syndrome, hyperglycemia, and glucosuria.
- Conditions that increase systemic absorption include prolonged use, application to large surface areas, use of occlusive dressings, and use in individuals with compromised skin barrier function (e.
- g.
- , severe burns).
- Pediatric patients may be more susceptible to systemic toxicity due to a larger skin surface area to body weight ratio.
- Localized adverse reactions, such as skin atrophy, striae, and telangiectasias, may occur, particularly with prolonged use on the face, groin, or axillae.
- Avoid contact with eyes, and do not use for ophthalmic purposes.
- In the presence of dermatological or rectal infections, an appropriate antifungal or antibacterial agent should be used concurrently.
- If a favorable response does not occur promptly, the corticosteroid should be discontinued until the infection has been adequately controlled.
- Use during pregnancy and lactation should only be considered if the potential benefit outweighs the potential risk to the fetus or infant.
How it Works (Mechanism of Action)
Hydrocortisone is a potent corticosteroid that exerts its therapeutic effects primarily through its anti-inflammatory, antipruritic, and vasoconstrictive actions. At the cellular level, it diffuses across cell membranes and complexes with specific cytoplasmic receptors. These complexes then enter the nucleus, bind to DNA (chromatin), and stimulate or inhibit the transcription of messenger RNA (mRNA) and subsequently the synthesis of various enzymes. This leads to the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. Lipocortins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor, arachidonic acid, from membrane phospholipids. Hydrocortisone also suppresses the migration of neutrophils to the site of inflammation, reduces the production of histamine from mast cells, and decreases the permeability of capillaries, thereby reducing edema and swelling. These combined actions result in the reduction of inflammation, pruritus, and discomfort associated with various dermatological and anorectal conditions.